DK0863752T3 - Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion. - Google Patents

Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.

Info

Publication number
DK0863752T3
DK0863752T3 DK96924889T DK96924889T DK0863752T3 DK 0863752 T3 DK0863752 T3 DK 0863752T3 DK 96924889 T DK96924889 T DK 96924889T DK 96924889 T DK96924889 T DK 96924889T DK 0863752 T3 DK0863752 T3 DK 0863752T3
Authority
DK
Denmark
Prior art keywords
terbinafine
medicament
pylori infection
manufacture
treatment
Prior art date
Application number
DK96924889T
Other languages
English (en)
Inventor
Ivan James Dalton Lindley
Neil Stewart Ryder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0863752T3 publication Critical patent/DK0863752T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
DK96924889T 1995-07-06 1996-07-05 Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion. DK0863752T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513750.1A GB9513750D0 (en) 1995-07-06 1995-07-06 Use of allylamines
PCT/EP1996/002970 WO1997002026A1 (en) 1995-07-06 1996-07-05 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Publications (1)

Publication Number Publication Date
DK0863752T3 true DK0863752T3 (da) 2003-04-22

Family

ID=10777201

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96924889T DK0863752T3 (da) 1995-07-06 1996-07-05 Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.

Country Status (27)

Country Link
US (1) US5935998A (da)
EP (1) EP0863752B1 (da)
JP (1) JP3680950B2 (da)
KR (1) KR100425401B1 (da)
CN (1) CN1204881C (da)
AT (1) ATE232723T1 (da)
AU (1) AU715270B2 (da)
CA (1) CA2219678C (da)
CY (1) CY2465B1 (da)
CZ (1) CZ289440B6 (da)
DE (1) DE69626301T2 (da)
DK (1) DK0863752T3 (da)
ES (1) ES2192608T3 (da)
GB (1) GB9513750D0 (da)
HK (1) HK1011527A1 (da)
HU (1) HU224311B1 (da)
IL (1) IL122853A (da)
MX (1) MX9710093A (da)
MY (1) MY132436A (da)
NO (1) NO317496B1 (da)
PL (1) PL187704B1 (da)
RU (1) RU2193402C2 (da)
SI (1) SI0863752T1 (da)
SK (1) SK282874B6 (da)
TW (1) TW522011B (da)
WO (1) WO1997002026A1 (da)
ZA (1) ZA965749B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) * 2002-02-05 2003-08-09 한솔케미언스 주식회사 (ｅ)-터비나핀 또는 이의 염산염의 제조방법
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE3020113A1 (de) * 1979-06-08 1980-12-18 Sandoz Ag 2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
DE4317449A1 (de) * 1993-05-19 1994-11-24 Asche Ag Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

Also Published As

Publication number Publication date
GB9513750D0 (en) 1995-09-06
HUP9802929A3 (en) 1999-10-28
EP0863752B1 (en) 2003-02-19
MX9710093A (es) 1998-03-31
ZA965749B (en) 1998-01-05
WO1997002026A1 (en) 1997-01-23
CN1204881C (zh) 2005-06-08
CN1189775A (zh) 1998-08-05
JPH11508580A (ja) 1999-07-27
NO317496B1 (no) 2004-11-08
IL122853A0 (en) 1998-08-16
AU715270B2 (en) 2000-01-20
RU2193402C2 (ru) 2002-11-27
ATE232723T1 (de) 2003-03-15
PL323305A1 (en) 1998-03-16
SI0863752T1 (en) 2003-06-30
CZ1798A3 (cs) 1998-03-18
EP0863752A1 (en) 1998-09-16
CA2219678C (en) 2006-10-10
KR100425401B1 (ko) 2004-07-16
PL187704B1 (pl) 2004-09-30
HUP9802929A2 (hu) 1999-09-28
NO975790D0 (no) 1997-12-09
TW522011B (en) 2003-03-01
SK282874B6 (sk) 2003-01-09
JP3680950B2 (ja) 2005-08-10
NO975790L (no) 1997-12-09
CZ289440B6 (cs) 2002-01-16
HU224311B1 (hu) 2005-07-28
DE69626301T2 (de) 2003-10-16
DE69626301D1 (de) 2003-03-27
IL122853A (en) 2001-04-30
AU6519596A (en) 1997-02-05
KR19990028725A (ko) 1999-04-15
CA2219678A1 (en) 1997-01-23
CY2465B1 (en) 2005-06-03
SK698A3 (en) 1998-05-06
ES2192608T3 (es) 2003-10-16
MY132436A (en) 2007-10-31
US5935998A (en) 1999-08-10
HK1011527A1 (en) 1999-07-16

Similar Documents

Publication Publication Date Title
NO960067L (no) Nytt farmasöytisk preparat
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
DE122010000050I1 (de) Sublinguales oder bukkales arzneimittel
ATE248837T1 (de) Chinuclidin-acrylamide
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
SE9401728D0 (sv) New compounds II
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
BR0113590A (pt) 7-oxo-piridopirimidinas
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
DK0863752T3 (da) Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.
BR9506956A (pt) Composição farmacêutica antitussígena
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
SE9302218D0 (sv) New use
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
DK0766695T3 (da) Pyrrolidinderivater til behandling af CCK- og gastrinrelaterede sygdomme
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)